Cancer, Lung Clinical Trial
Official title:
A Stepped-Care Intervention to Reduce Disparities in Mental Health Services Among Underserved Lung and Head and Neck Cancer Patients and Their Caregivers
Verified date | February 2021 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Medically under-served (i.e., low-income, uninsured, underinsured) cancer patients generally encounter significant disparities in accessing care for their mental health needs while undergoing toxic treatments that provide considerable physical and emotional stress. Thus, the investigators propose to adapt evidence-based strategies to a stepped-care intervention model to address the mental health needs of under-served lung cancer (LC) and head and neck cancer (HNC) patients and their caregivers across several levels of symptom severity (e.g., mild, moderate, or severe symptoms of depression and anxiety).
Status | Completed |
Enrollment | 535 |
Est. completion date | July 17, 2020 |
Est. primary completion date | July 17, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | 1. LC and HNC patients: Inclusion Criteria: - Newly diagnosed LC and/or HNC (within a month of recruitment date from the date of 1st visit oncology, Ear Nose and Throat (ENT), or radiation clinic visit/consultation upon pathologic tissue diagnosis; - LC and/or HNC patients at any stage of diagnosis (Stages 0-IV); - Over 18 years old; - English and/or Spanish speaking; - Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: e.g.: Public insurance (Medicaid, Medicare exclusive, VA); and/or 10% of annual income on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty levels. Exclusion Criteria: - Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish; - Those who refuse treatment at one of three hospital sites; - Decisionally-challenged adults with cognitive or personality impairment; - Suicidal ideation, or - Intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study; - Individuals from vulnerable populations (e.g., inmates or individuals on probation, - homeless, - pregnant women, and - those with auditory impairment. Note: Individuals who become pregnant or develop auditory impairments after they have been randomized to study condition may remain in the study until completion. 2. Caregivers of LC and/or HNC patients Inclusion Criteria: - Primary caregiver of a newly diagnosed LC and/or HNC patient (per criteria for patients); - Over 18 years old; - English and/or Spanish speaking; - Medically underserved, as defined by at least one or several of the following: 1. Low-income: Below 400% of the 2016 Federal poverty levels; 2. Uninsured: No health insurance (public or private insurance); 3. Underinsured: - (c.1) Public insurance (i.e., Medicaid, Medicare exclusive, VA); - (c.2) 10% of annual income spent on out-of-pocket medical expenses for individuals below 200% of the 2016 Federal poverty level. Exclusion criteria: - Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish [at the discretion of the Site Coordinators upon recruitment]; - Caregivers of patients who refuse treatment at one of three hospital sites. - Decisionally challenged adults with: 1. cognitive or personality impairment, 2. suicidal ideation, or 3. intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study [at the discretion of the Site Coordinators upon recruitment or the Counselor during the intervention]; - Individuals from: 1. vulnerable populations (e.g., inmates or individuals on probation, homeless, 2. pregnant women, and 3. those with auditory impairment [at the discretion of the Site Coordinators upon recruitment]). 4. Individuals who become pregnant or develop auditory impairments after they have been randomized to study condition may remain in the study until completion. |
Country | Name | City | State |
---|---|---|---|
United States | Denver Health Medical Center | Denver | Colorado |
United States | National Jewish Health | Denver | Colorado |
United States | Saint Joseph Hospital | Denver | Colorado |
United States | University of Colorado Denver | Denver | Colorado |
United States | Saint Mary's Hospital and Regional Medical Center | Grand Junction | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Symptoms of Depression-Patients | Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer (CA) Form v1.0 - Depression (30 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses. | 6-months | |
Primary | Symptoms of Anxiety-Patients | Patient-Reported Outcomes Measurement Information System, Anxiety (PROMIS-Ca) Form v1.0- Anxiety (22 items). The range of scores is between 8 and 40. The raw scores were used. Higher score corresponds to worse outcome. | 6-months | |
Primary | Change in Coping-Patients | Coping Self-Efficacy (26 items). Scores can rage from 0 to 260. Higher score corresponds to better outcome. | 6-months | |
Secondary | Change in Coping-Caregivers | Coping Self-Efficacy (26 items). Higher score corresponds to better outcome. Scores can rage from 0 to 260.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively. |
6-months | |
Secondary | Symptoms of Anxiety-Caregivers | PROMIS Form v1.0 - Anxiety (29 items). The range of scores is from 8 to 40. Higher score indicates worse outcome (higher anxiety). Raw scores were used in analyses.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively. |
6-months | |
Secondary | Symptoms of Depression-Caregivers | PROMIS Form v1.0 - Depression (28 items). The range is from 8 to 40. Higher score indicates worse outcome (higher depression). Raw scores were used in analyses.
The number of caregivers randomized and analyzed was 118 and 131 in the enhanced usual care and intervention groups, respectively. |
6-months | |
Secondary | Health-Related Quality of Life-Patients | FACT-G version 4 (27 items). The range is 0-108. Higher values indicate better QOL. | 6-months | |
Secondary | Perceived Stress-Patients | Perceived Stress Scale (PSS) (14 items). The range of scores is 0-40. Higher values indicate higher stress. | 6-months | |
Secondary | Perceived Stress-Caregivers | Perceived Stress Scale (PSS) (14 items). The range is from 0 to 40. Higher values indicate higher stress. | 6-months | |
Secondary | Caregiving Burden-Caregivers | Zarit Burden Interview (ZBI) (12 items). The range of scores is 0-48. Higher scores represent higher burden. | 6-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Recruiting |
NCT04105647 -
Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study
|
N/A | |
Completed |
NCT05732350 -
Exploratory Drug Interaction Study Between SMIs and DOACs
|
||
Active, not recruiting |
NCT04300244 -
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
|
Phase 2 | |
Recruiting |
NCT05311709 -
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
|
Phase 2 | |
Active, not recruiting |
NCT04396457 -
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
|
Phase 2 | |
Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
Completed |
NCT04788147 -
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
|
N/A | |
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Recruiting |
NCT03274349 -
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
|
N/A | |
Recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02991677 -
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
|
N/A | |
Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
Recruiting |
NCT04859400 -
Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients
|
N/A | |
Recruiting |
NCT05948865 -
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04270890 -
Investigation of an Abdominal Compression Device
|
N/A | |
Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A |